Global Artificial Intelligence (AI) In Drug Discovery Market Overview And Top Key Players by 2030

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact – both negative and positive – of COVID-19 on the artificial intelligence (AI) in drug discovery industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. This includes revised market numbers according to the effects of the coronavirus and the expected artificial intelligence (AI) in drug discovery market growth numbers 2021-2030.

View Complete Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-drug-discovery-global-market-report-2020-30-covid-19-growth-and-change

The Artificial Intelligence (AI) In Drug Discovery Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global artificial intelligence (AI) in drug discovery market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030. The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Artificial Intelligence (AI) In Drug Discovery Global Market Report 2021 covers artificial intelligence (AI) in drug discovery market drivers, artificial intelligence (AI) in drug discovery market trends, artificial intelligence (AI) in drug discovery market growth rate, artificial intelligence (AI) in drug discovery market major players, player-adopted strategies in the market, and artificial intelligence (AI) in drug discovery market size.

The global artificial intelligence (AI) in drug discovery market is expected to grow from $0.36 billion in 2020 to $0.47 billion in 2021 at a compound annual growth rate (CAGR) of 30.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The AI in drug discovery market is expected to reach $1.69 billion in 2025 at a CAGR of 38%.

Request For The Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

The report covers the artificial intelligence (AI) in drug discovery market segments-
1) By Technology: Deep Learning, Machine Learning

2) By Drug Type: Small Molecule, Large Molecules

3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Others

4) By End-Users: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Others

About The Business Research Company:
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter: https://twitter.com/tbrc_info

Check out our Blog: http://blog.tbrc.info/

(Visited 1 times, 1 visits today)

Comments

comments

You may also like...